Patent · US Active

Pharmaceutical composition for preventing or treating hyperlipidemia

US9724336B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2012
Grant dateAug 8, 2017
Priority date
Expiry dateNov 28, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D263/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and an angiotensin II receptor blocker as active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.